Skip to content

Guardant Health

US · GH #820 by market cap Listed 2018
168.33 -2.36 -1.38%
Live - 5344 symbols - heartbeat 389s ago · 2026-10-08 07:03
Pre-market 168.33 0.00%
After-hours 168.33 0.00%
Overnight 167.98 -0.21%
Market cap
22.59B
P/B
-101.34
EPS
-3.32
Reader sentiment Are you bullish or bearish on GH?

Anonymous reader poll. Unscientific, not investment advice.

Recent news

  • Rating change
    Wells Fargo Maintains GH Research(GHRS.US) With Buy Rating, Maintains Target Price $44
    Market Newswire · 2026/8/31
  • Bernstein Maintains Guardant Health(GH.US) With Buy Rating, Maintains Target Price $210
    Market Newswire · 2026/9/26
  • Barclays Maintains Guardant Health(GH.US) With Buy Rating, Maintains Target Price $200
    Market Newswire · 2026/9/18
  • Company notice
    HHRG-WB (HHRG BHD): Changes in Sub. S-hldr's Int (Section 138 of CA 2016) - GH CONSORTIUM SDN BHD
    Bursa Malaysia · 2026/2/12
  • Analysts Are Bullish on These Healthcare Stocks: NeurAxis, Inc. (NRXS), Guardant Health (GH)
    TipRanks · 2026/9/16
  • Rating change
    H.C. Wainwright Maintains GH Research(GHRS.US) With Buy Rating, Maintains Target Price $65
    Market Newswire · 2026/8/10
  • Rating change
    Piper Sandler Maintains Guardant Health(GH.US) With Buy Rating, Maintains Target Price $193
    Market Newswire · 2026/9/15
  • Company notice
    GH Law Firm (Hangzhou) Legal Opinion on Hangzhou Silan Microelectronics Co., Ltd.'s Fourth Extraordinary General Meeting of Shareholders in 2024.
    SZSI · 2024/6/29
  • Rating change
    William Blair Maintains Guardant Health(GH.US) With Buy Rating
    Market Newswire · 2026/9/8
  • Goldman Sachs Maintains Guardant Health(GH.US) With Buy Rating, Raises Target Price to $225
    Market Newswire · 2026/9/21
  • Company notice
    GH Research | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-RA Capital Management, L.P.(12.9%),Peter Kolchinsky(12.9%), etc.
    SEC · 2024/11/15
  • Company notice
    HHRG-WB (HHRG BHD): Changes in Sub. S-hldr's Int (Section 138 of CA 2016) - GH CONSORTIUM SDN BHD
    Bursa Malaysia · 2026/1/29
  • Rating change
    CCORF Maintains GH Research(GHRS.US) With Buy Rating, Maintains Target Price $39
    Market Newswire · 2026/8/8
  • Rating change
    Rothschild & Co Redburn Initiates Guardant Health(GH.US) With Buy Rating, Announces Target Price $203
    Market Newswire · 2026/9/8
  • Rating change
    BTIG Maintains Guardant Health(GH.US) With Buy Rating, Maintains Target Price $195
    Market Newswire · 2026/9/2
  • Rating change
    Bernstein Maintains Guardant Health(GH.US) With Buy Rating, Raises Target Price to $210
    Market Newswire · 2026/9/9
  • Craig-Hallum Maintains Guardant Health(GH.US) With Buy Rating
    Market Newswire · 2026/9/16
  • Rating change
    Goldman Sachs Maintains Guardant Health(GH.US) With Buy Rating, Maintains Target Price $210
    Market Newswire · 2026/9/9
  • Rating change
    Analysts Are Bullish on These Healthcare Stocks: Fractyl Health, Inc. (GUTS), Guardant Health (GH)
    TipRanks · 2026/9/2
  • Company notice
    HHRG-WB (HHRG BHD): Changes in Sub. S-hldr's Int (Section 138 of CA 2016) - GH CONSORTIUM SDN BHD
    Bursa Malaysia · 2026/5/19

Headlines are aggregated automatically and are not independently verified or edited by our team.

Quote time 2026-10-08 07:03:28 · For reference only, not investment advice and not tailored to your situation.